1. Home
  2. IQV vs CBOE Comparison

IQV vs CBOE Comparison

Compare IQV & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • CBOE
  • Stock Information
  • Founded
  • IQV 1982
  • CBOE 1973
  • Country
  • IQV United States
  • CBOE United States
  • Employees
  • IQV N/A
  • CBOE N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • CBOE Investment Bankers/Brokers/Service
  • Sector
  • IQV Health Care
  • CBOE Finance
  • Exchange
  • IQV Nasdaq
  • CBOE Nasdaq
  • Market Cap
  • IQV 25.6B
  • CBOE 23.7B
  • IPO Year
  • IQV 2013
  • CBOE 2010
  • Fundamental
  • Price
  • IQV $154.78
  • CBOE $225.87
  • Analyst Decision
  • IQV Buy
  • CBOE Hold
  • Analyst Count
  • IQV 20
  • CBOE 13
  • Target Price
  • IQV $226.80
  • CBOE $223.31
  • AVG Volume (30 Days)
  • IQV 2.3M
  • CBOE 678.2K
  • Earning Date
  • IQV 07-21-2025
  • CBOE 08-01-2025
  • Dividend Yield
  • IQV N/A
  • CBOE 1.11%
  • EPS Growth
  • IQV 0.26
  • CBOE 2.12
  • EPS
  • IQV 7.35
  • CBOE 7.62
  • Revenue
  • IQV $15,497,000,000.00
  • CBOE $4,332,300,000.00
  • Revenue This Year
  • IQV $5.37
  • CBOE N/A
  • Revenue Next Year
  • IQV $5.19
  • CBOE $4.18
  • P/E Ratio
  • IQV $21.12
  • CBOE $29.88
  • Revenue Growth
  • IQV 2.84
  • CBOE 15.76
  • 52 Week Low
  • IQV $134.65
  • CBOE $166.88
  • 52 Week High
  • IQV $252.88
  • CBOE $236.02
  • Technical
  • Relative Strength Index (RSI)
  • IQV 55.12
  • CBOE 52.20
  • Support Level
  • IQV $153.23
  • CBOE $223.61
  • Resistance Level
  • IQV $159.85
  • CBOE $229.00
  • Average True Range (ATR)
  • IQV 4.39
  • CBOE 3.82
  • MACD
  • IQV 0.96
  • CBOE -0.04
  • Stochastic Oscillator
  • IQV 67.09
  • CBOE 57.05

About IQV IQVIA Holdings Inc.

Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About CBOE Cboe Global Markets Inc.

Cboe Global Markets Inc is a provider of market infrastructure and tradable products, that delivers cutting-edge trading, clearing, and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive all over world marketplace, and to providing products, technology, and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.

Share on Social Networks: